Retrograde Retrieval of a Novel Large Mitral Clip After Embolization Into the Left Ventricle.
DCM, dilated cardiomyopathy
LV, left ventricle
LVAD, left ventricular assist device
LVEF, left ventricular ejection fraction
MitraClip G4
SLDA, single leaflet device attachment
SMR, secondary mitral regurgitation
TEER, transcatheter edge-to-edge repair
clip retrieval
complications
embolization
single leaflet device attachment
transcatheter edge-to-edge repair
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
20 Oct 2021
20 Oct 2021
Historique:
received:
15
06
2021
revised:
19
08
2021
accepted:
26
08
2021
entrez:
3
11
2021
pubmed:
4
11
2021
medline:
4
11
2021
Statut:
epublish
Résumé
We describe the successful retrieval of a novel large mitral clip, which embolized in a patient with severe secondary mitral regurgitation and left ventricular dysfunction, dilated left ventricle, and severely tethered mitral valve leaflets in the setting of a challenging anatomy for transcatheter edge-to-edge repair. The description highlights planning, technical issues, and possible adverse events of this bailout procedure. (
Identifiants
pubmed: 34729501
doi: 10.1016/j.jaccas.2021.08.024
pii: S2666-0849(21)00838-X
pmc: PMC8543158
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1561-1568Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
Dr Windecker has received research and educational grants to the institution from Abbott, Amgen, Bristol Myers Squibb, Bayer, Boston Scientific, Biotronik, Cardinal Health, Cardiovalve, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson & Johnson, Medtronic, Querbet, Polares, Sanofi, Terumo, and Sinomed; has served as an unpaid member of the steering and executive groups of trials funded by Abbott, Abiomed, Amgen, Bristol Myers Squibb, Boston Scientific, Biotronik, Cardiovalve, Edwards Lifesciences, MedAlliance, Medtronic, Polares, Sinomed, V-Wave, and Xeltis, for which he received no personal payments from any pharmaceutical company or device manufacturer; and has been a member of the steering and executive committee groups of several investigated-initiated trials that receive funding from industry without impact on his personal remuneration. Dr Praz has received travel expenses from Abbott Vascular, Edwards Lifesciences, and Polares Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Références
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1356-1365
pubmed: 31129091
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1907-8
pubmed: 26604053
Can J Cardiol. 2013 Jun;29(6):751.e17
pubmed: 23218468
JACC Cardiovasc Interv. 2020 Oct 26;13(20):2415-2417
pubmed: 33011143
Circ Cardiovasc Interv. 2016 Nov;9(11):
pubmed: 27810965
Catheter Cardiovasc Interv. 2020 Jul;96(1):210-214
pubmed: 31617308
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1342-1352
pubmed: 31320029
JACC Cardiovasc Interv. 2019 Dec 23;12(24):e211-e213
pubmed: 31563685
EuroIntervention. 2021 May 25;:
pubmed: 34031024
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1201-1203
pubmed: 29860073